Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Int J Drug Policy. 2014 Oct 28;26(2):175–182. doi: 10.1016/j.drugpo.2014.10.002

Table 2.

Patient Characteristics

Participant Number Age (Years) Patient Status Self-reported Comorbidities Drug of Choice Daily Methadone Dosage (mg)
1 36 Outpatient HIV, TB, HCV, Depression Opioids 50
2 20 Inpatient None Syabu, Meth, Ice N/A
3 21 Inpatient None Pil Kuda* N/A
4 41 Outpatient HIV, TB, HCV Opioids N/A
5 50 Outpatient HIV, HBV, HCV, Hypertension Opioids 120
6 41 Outpatient HIV, TB, HBV Opioids 21
7 45 Outpatient HIV, HCV Opioids N/A
8 36 Outpatient None Opioids N/A
9 18 Outpatient Asthma, Depression Pil Kuda* N/A
10 32 Outpatient HCV, Depression Opioids 90
11 30 Inpatient HCV Opioids 60
12 24 Outpatient None Pil Kuda* N/A
13 38 Inpatient Asthma Opioids N/A
14 22 Outpatient None Pil Kuda* N/A
15 28 Inpatient HBV Opioids 50
16 20 Outpatient Asthma Pil Kuda* N/A
17 23 Inpatient None Pil Kuda* N/A
18 30 Inpatient Asthma Pil Kuda* N/A
19 29 Inpatient HCV Opioids N/A
20 43 Peer Support None Opioids 2.5
*

Pil Kuda is an amphetamine-type substance